Proteomics: market research reports

Market Research > Browse Research > Life Sciences > Biotechnology

The study of proteins, their parts and their functions is proteomics. The culmination the human genome project’s historic achievement to sequence the three billion DNA bases that define the genetic map of human body has been completed. The human genome project provides us with a precise three-gigabit map of every gene that codes for the component parts that define the human body.

However, the genome is a static molecule that merely contains the information that directs another group of molecules’ actions. The ultimate function of a gene is to provide the blueprint for the construction of proteins. Genomics, sequencing of DNA, is broadening our understanding of the genome and has defined the next step in biological research: determining the functions of proteins. Sequencing DNA will be able to tell us the specific chemical composition of each protein but it will not be able to tell us what function the protein actually performs or participates in when active.

Thus, the focus of biological research in the post-genomic era is shifting to protein research. Proteins are the essential building blocks produced by DNA. A protein consists of a chain of amino acids, which folds into a characteristic shape and may be modified chemically before it becomes physiologically active.

Proteomics market research reports and industry analysis

Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Global Forecast to 2018 3/31/2014 \| published by: MarketsandMarkets ... owing to the increasing demand for proteomics techniques in drug discovery and diagnostics applications. The availability of research funds across the globe, which increases the purchasing power of research and academic institutes is also playing ... \| read more...	$4,650.00
Proteins in Oncology Drug Pipeline Update 2014 3/25/2014 \| published by: BioSeeker Group AB ... 661 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 186 drugs. Proteins In Oncology Drug Pipeline Update lists ... \| read more...	$5,622.50
Proteins in Oncology: Drug Pathway Analyzer 2014 3/25/2014 \| published by: BioSeeker Group AB ... intracellular signaling pathways for the treatment of more than 79 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 160 drug targets that are included ... \| read more...	$5,622.50
Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Forecasts to 2017 3/7/2014 \| published by: MarketsandMarkets ... is an integration of informatics and life sciences. It uses information technology, statistics, and algorithms for storing, retrieving, and analyzing biological data that is generated during life sciences research. In Latin America, bioinformatics is now ... \| read more...	$4,650.00
Competitive Intelligence 2014: Global Animal Health Market Outlook and Leading Suppliers' Strategies, Marketing Tactics, and Technological Know-How 3/3/2014 \| published by: Venture Planning Group ... marketing tactics, and technological know-how. The report presents a worldwide strategic overview of the animal health market, including: Five-year forecasts for: - Major market segments - Key geographic regions Assessment of major U.S. and international ... \| read more...	$4,850.00
Vital Signs - Healthcare News - The Analyst's Perspective February 2014 Issue 2/28/2014 \| published by: Frost & Sullivan ... 2014, discusses three M&A transactions this month by Nestle, Myriad Genetics, and Fludigm' and what these deals mean for the industry. Additionally, Illumina's first stab at personalized medicine through a partnership with Amgen is explored. \| read more...	$450.00
Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018 2/19/2014 \| published by: MarketsandMarkets ... the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various technological advancements. These advancements have led to a growth in the number of gene expression applications. Some of the applications using ... \| read more...	$4,650.00
Profiling of Select Biotech Markets in Asia - 2014 1/17/2014 \| published by: Feedback Business Consulting Services Pvt. Ltd. ... Industrial, Bio informatics, Others Key user segments - Medical biotech (Pharma/Vaccines), Food ingredients and flavor, Nutraceuticals, Others Key players - Global Players, Domestic Players Market Profile for each countries - South Korea, Taiwan, China + ... \| read more...	$2,500.00
Proteomics (Global) - Industry Report 1/8/2014 \| published by: Plimsoll Publishing Ltd. ... This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Proteomics (Global) analysis is ideal for anyone wanting to: See the market leaders Identify companies heading ... \| read more...	$1,425.00
Biological Machines Trends 1/1/2014 \| published by: Global Industry Analysts ... can be defined as cellular devices designed to carry out certain functions such as sensing, protein expression, transport, information processing and actuation, inside a micro-environment." In addition, the report also details about the development of ... \| read more...	$950.00
In Vitro Toxicity Testing: Technologies and Global Markets 1/1/2014 \| published by: BCC Research ... reach nearly $9.9 billion in 2017, with a compound annual growth rate (CAGR) of 14.7% for the five-year period, 2012 to 2017. This report provides: An overview of the global in vitro toxicity testing market, ... \| read more...	$6,650.00
Global Protein Therapeutics Market Outlook 2018 1/1/2014 \| published by: RNCOS ... clinical methods to treat a wide spectrum of diseases ranging from cancer to metabolic disorders. The market holds tremendous potential for future growth and it is estimated that by the end of 2018, it may ... \| read more...	$1,800.00
Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018 12/17/2013 \| published by: MarketsandMarkets ... microfluidics market is valued at an estimated $1.59 billion in 2013 and is expected to grow at a CAGR of 17.6% in the next five years. The high growth in this market can be attributed ... \| read more...	$4,650.00
Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective - Overview 12/1/2013 \| published by: CHI Insight Pharma Reports ... mostly pertaining to epigenetic targets, and the reasons they are being investigated. Several companies have kindly disclosed several strategies, methods, and techniques that they use for either target identification or technology development. Report Features Include: ... \| read more...	$2,495.00
Global Epigenetics Market 2014-2018 11/29/2013 \| published by: Infiniti Research Limited - TechNavio ... be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors to provide the most accurate and detailed ... \| read more...	$2,000.00
Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast to 2018 11/22/2013 \| published by: MarketsandMarkets ... non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant non-glycosylated proteins market is further segmented as insulin, granulocyte colony-stimulating factor (G-CSF), interferons, and human growth hormone; whereas the recombinant glycosylated proteins market is further ... \| read more...	$4,650.00
Opportunity in the Indian Protein A Media Market - 2014 10/24/2013 \| published by: Feedback Business Consulting Services Pvt. Ltd. ... estimates Market size by product categories - Sepharose Series, Mabselect Series, Others Market size by end user segments - Biotech OEMs (Bio Pharmaceutical Firms), Research Institutes, Medical Diagnostics Market size by product supply categories - ... \| read more...	$5,000.00
Profiling of Select Biotech Markets in Asia - 2014 10/24/2013 \| published by: Feedback Business Consulting Services Pvt. Ltd. ... Biotech segments - Medical biotech, Agriculture biotech, Clean Energy, Bio Industrial, Bio informatics, Others Key user segments - Medical biotech (Pharma/Vaccines), Food ingredients and flavor, Nutraceuticals, Others Key players - Global Players, Domestic Players Market ... \| read more...	$2,500.00
China Mouse Nerve Growth Factor Injection Market Analysis 10/14/2013 \| published by: Reports From China ... or export from China, to build factories and take advantage of lower costs in China, to partner with one of the key Chinese corporations, to get market shares as China is boosting its domestic needs; ... \| read more...	$3,980.00
Global Markets and Manufacturing Technologies for Protein Drugs 10/1/2013 \| published by: BCC Research ... blood products Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018 Examinations of current successes, including the size and sales forecast for ... \| read more...	$6,650.00
Global Markets and Manufacturing Technologies for Protein Drugs - Focus on Peptide Hormones and Therapeutic Enzymes 10/1/2013 \| published by: BCC Research ... hormones and therapeutic enzymes. Analyses of market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) for the period 2013 to 2018. Examinations of current successes, ... \| read more...	$4,400.00
Global Markets and Manufacturing Technologies for Protein Drugs - Focus on Cytokines and Monoclonal Antibodies 10/1/2013 \| published by: BCC Research ... and monoclonal antibodies Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018 Examinations of current successes, including size and sales forecasts for this ... \| read more...	$4,400.00
Global Markets and Manufacturing Technologies for Protein Drugs - Focus on Blood Factors, Vaccines and Peptide Antibiotics 10/1/2013 \| published by: BCC Research ... blood factors, vaccines, and peptide antibiotics. Analyses of market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) for the period 2013 to 2018. Examinations of ... \| read more...	$4,400.00
Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018 9/30/2013 \| published by: MarketsandMarkets ... significant growth in the healthcare industry. It is poised to grow rapidly in a range of application areas, including biomarker discovery and prognosis. The global cancer/tumor profiling market is valued at $14.99 billion in 2013 ... \| read more...	$4,650.00
Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends and Forecasts (2013 – 2 9/25/2013 \| published by: MarketsandMarkets ... and measurable characteristic, which identifies the severity and/or occurrence of a specific disease. It has major applications in the discovery and development of novel therapeutic drugs. The global biomarkers market shows a high growth potential ... \| read more...	$4,650.00

< prev 1 2 3 4 5 6 next >

Our Clients